EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark AI is where the data is was filed as Word mark on 06/17/2021 at the European Union Intellectual Property Office.
It was registered as a trademark on 12/02/2021.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018495423 |
| Application date | June 17, 2021 |
| Publication date | August 25, 2021 |
| Entry date | December 2, 2021 |
| Expiration date | June 17, 2031 |
Trademark owner
Paul-Ehrlich-Strasse 15
72076 Tübingen
DE
72076 Tübingen
DE
Trademark representatives
Avenida Federico Soto 13
03003 Alicante
ES
goods and services
9
Bioinformatics software; graphical user interface software; artificial intelligence and machine learning software for genome analysis, developing personal treatment strategies for patients with diagnosed cancer, analyzing, screening, identifying, quantifying, and interpreting data in the field of mass spectrometry and next-generation sequencing (NGS); electronic databases for bioinformatic purposes; next-generation sequencing (NGS) data processor; bioinformatics data processor; computer software
35
Business statistical services and modeling with respect to cancer treatment and cancer diagnosis
42
Computer programming in the medical, pharmaceutical and biotechnological field; database design; database maintenance; programming of software for importing and managing data; information technology services for the pharmaceutical and healthcare industries; Computer programming for data processing; non-downloadable computer software; conducting evaluations in the field of pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development and evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; conducting clinical trials in the field of pharmaceuticals for the treatment and prevention of cancer; collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; research and development of medicines and diagnostic agents for cancer treatment and cancer diagnosis; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis in the field of next-generation sequencing (NGS) with respect to the analysis and interpretation of genomic data obtained from cancer patients; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice; research and development services in the field of immunology
44
Medical and pharmaceutical services
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| August 3, 2023 | Change Representative, Published | ||
| August 22, 2022 | Change Representative, Published | ||
| April 6, 2022 | Change Representative, Published |
ID: 11018495423